17 May | 12:15 -13:15 CEST | Room 252B
Moderator : Roberto Garbo
Anchorperson: Dariusz Dudek
Speakers: Nieves Gonzalo, Javier Escaned, Ajay J Kirtane, Abdul Mozid
16 May | 13:45-14:30 CEST | Studio A
Moderator : Rasha Al-Lamee
Anchorperson: Nieves Gonzalo
Speakers: Matthias Götberg, Javier Escaned, Eric Van Belle
Tuesday 16 May – 12:00-13:30 – Room Maillot Dynamic coronary roadmap for contrast reduction trial, Javier Escaned Thursday 18 May – 15:15-16:45 – Room Maillot
iFR vs. FFR-guided revascularisation decision-making in left main disease,
Takayuki Warisawa
DEFINE-FLAIR: five-year follow-up, Javier Escaned
Our solutions support interventionalists in minimizing the contrast-load for the patient and physicians, and in performing interventional procedures with clarity and confidence, improving cardiac care experiences for staff and patients. Join our training village at EuroPCR and learn more.
In-depth research identified a number of critical factors that could successfully address challenges in the care pathway.
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.
World’s first solid core pressure guide wire. With an all-new workhorse design, only Philips OmniWire pressure guide wire combines confidence in wire performance with proven iFR outcomes and iFR Co-registration, making it easy to benefit from physiology throughout the case.
IntraSight Mobile is an easy-to-use, small footprint, IVUS imaging and physiology system, designed for coronary and peripheral vascular procedures, operable directly from the sterile field.
Most cardiac patients fall under high-risk category for acute kidney injury (AKI) 1
Philips Interventional Hemodynamic system (Hemo system) brings advanced hemodynamic measurements to the cath lab to support clinical decision making. Integrated with the state-of-the-art IntelliVue X3 patient monitor and Azurion, this system helps further simplify your cath lab workflow.
The IntelliVue X3 portable monitor stays connected to the patient for consistent physiological monitoring and timely detection of potential adverse events during every stage of their journey.
Sign up to receive news and updates on our new innovations in cardiology that deliver clinical confidence and efficiency in the diagnosis and treatment in CAD and SHD.
iFR Co-registration
IVUS guidance
Coronary diagnostic for Complex PCI
IntelliSpace Cardiovascular
Joost Maltha Joost.maltha@philips.com Philips Global Press Office Tel: +31 6 10 55 8116
References:
1 Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7): 1393-1399. doi:10.1016/j.jacc.2004.06.068.
You are about to visit a Philips global content page
Continue